May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Disease Progression in a Family With Autosomal Dominant Macular Dystrophy Linked to Arg172trp Mutation in Rds/peripherin
Author Affiliations & Notes
  • I. A. Meunier
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • S. Ben Salah, Sr.
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • C. Arndt
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • S. Lopez
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • B. Bocquet
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • C. Dhaenens
    Centre de Biologie Moléculaire, Lille, France
  • D. Allorge
    Centre de Biologie Moléculaire, Lille, France
  • C. P. Hamel
    Centre National de Reference Maladies Rares Affections Sensorielles Genetiques, Montpellier, France
  • Footnotes
    Commercial Relationships  I.A. Meunier, None; S. Ben Salah, None; C. Arndt, None; S. Lopez, None; B. Bocquet, None; C. Dhaenens, None; D. Allorge, None; C.P. Hamel, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2971. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I. A. Meunier, S. Ben Salah, Sr., C. Arndt, S. Lopez, B. Bocquet, C. Dhaenens, D. Allorge, C. P. Hamel; Disease Progression in a Family With Autosomal Dominant Macular Dystrophy Linked to Arg172trp Mutation in Rds/peripherin. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2971.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe the disease progression in ten patients aged 9 to 60 from a single family segregating autosomal dominant macular dystrophy linked to the Arg172Trp RDS mutation.

Methods: : Evaluation of the patients included visual acuity testing, fundus and autofluorescence photographs, Goldmann visual fields, optical coherence tomography (Zeiss, OCT3), full field (ISCEV protocol) and multifocal ERGs.

Results: : Patients were asymptomatic with normal visual acuity until their early twenties, although a small perifoveal ring of increased autofluorescence was already detected. From 20 to 40 years of age, the visual acuity decreased moderately (mean value: 20/30). The macula showed pigment epithelium granularity and whitish deposits but the fovea looked unaffected. The perifoveal ring of increased autofluorescence was extending peripherally and included small points of decreased autofluorescence (first stage of atrophy). On OCT, there was first a decrease in thickness of the foveal margin and perifoveal area, later followed by a decrease in foveolar thickness. Accordingly, the multifocal ERG disclosed a predominant amplitude reduction in the perifoveal area. Full field ERG showed decreased 30-Hz flickers and red photopic responses while scotopic responses remained normal. By 40 years of age, visual acuity dropped to 20/400 with occurrence of an extended macular atrophy which reached the temporal superior and inferior arcades by 50 years of age.

Conclusions: : This observation shows that there is a progressive peripheral extension of the macular lesions outside the fovea, while the fovea itself is minimally affected until the 4th decade. Later on, severe visual loss occurred, caused by a large macular atrophy. This suggests that the pathogenic process affects first perifoveal photoreceptors (cones and rods), resembling the progression of perifoveal lesions observed in some cases of Stargardt macular dystrophy.

Keywords: macula/fovea • genetics • degenerations/dystrophies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×